Cullinan Oncology (CGEM) P/E (2021 - 2026)
Cullinan Oncology (CGEM) P/E from Jan 8, 2021 to Jul 21, 2026. The TTM Cullinan Oncology (CGEM) P/E is -4.89. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Cullinan Oncology (CGEM)
| Year | P/E | Change |
|---|---|---|
| 2026 | -4.89 | +75.35% |
| 2025 | -2.79 | -28.99% |
| 2024 | -3.93 | +43.70% |
| 2023 | -2.73 | -159.74% |
| 2022 | 4.58 | -144.25% |
| 2021 | -10.34 | N/A |
Comparison Cullinan Oncology (CGEM) P/E with competitors
Cullinan Oncology (CGEM) P/E is -4.89.